Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab in Advanced or Metastatic Cervical Cancer
NCT02095119Phase 2Completed
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Jul 2008
- Primary completion
- Dec 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nimotuzumab in Cervical Cancer (CC), sponsored by Instituto Nacional de Cancerología. Started Jul 2008; status: completed.
02
Drugs
nimotuzumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02095119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095119.